MARKET INTEL |
PRIME GRANT

Project - W81XWH2210762

OVERVIEW

Original Description
COMBINATION OF HBV IMMUNOTHERAPY WITH SHRNA-MEDIATED PD-1/PDL CHECKPOINT INHIBITION FOR TREATMENT OF CHRONIC HBV
Grant Program (CFDA)
Assistance Type
Project Grant (B)
Place of Performance
Hamden, Connecticut 065183025 USA
Related Opportunity
0011744156

STATUS

Period of Performance

9/15/22

Start Date

9/14/25

End Date
1.0% Complete

Funding Split

$5.5M

Federal Obligation

$0.0

Non-Federal Obligation

$5.5M

Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

ACTIVITY TIMELINE

SUBGRANT AWARDS

TRANSACTION HISTORY

ADDITIONAL DETAIL

Award ID FAIN
W81XWH2210762
SAI Number
None
Award ID URI
None
Awardee Classifications
Small Business
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Last Modified: 9/21/22